Skip to main content
Gujarat Themis Biosyn Ltd. logo

Gujarat Themis Biosyn Ltd. — Investor Relations & Filings

Ticker · GUJTHEM ISIN · INE942C01045 LEI · 3358009IT99XRO254Q79 BSE.NS Manufacturing
Open in API
Filings indexed 696 across all filing types
Latest filing 2026-04-20 Regulatory Filings
Country IN India
Listing BSE.NS GUJTHEM

About Gujarat Themis Biosyn Ltd.

https://www.gtbl.in

Gujarat Themis Biosyn Ltd. specializes in the manufacture of active pharmaceutical ingredients and intermediates through advanced fermentation technology. The company focuses on the production of fermentation-based bulk drugs, with a primary product portfolio that includes Rifampicin intermediates and Lovastatin. Utilizing large-scale fermentation processes, the organization engages in strain improvement and media optimization to enhance yield and efficiency. The company operates a dedicated manufacturing facility equipped for complex biotechnological processes. Through technical collaborations with international entities, it has integrated specialized expertise in fermentation science to support the development of high-purity chemical compounds. Its operations are centered on providing essential building blocks for various therapeutic applications, maintaining a focus on technical precision and process-driven manufacturing excellence.

Recent filings

Filing Released Lang Actions
Please refer to the attachment.
Regulatory Filings
2026-04-20 English
Please refer to the attachment.
Regulatory Filings
2026-04-20 English
Please refer to the attachment.
Regulatory Filings
2026-04-20 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a disclosure of shareholding under Regulation 31(4) of SEBI (Substantial Acquisition of Shares & Takeover) Regulations, 2011. It details that the promoter and promoter group have not made any encumbrance over shares during the financial year ended 31 March 2026, and references prior disclosures of pledged shares. This is a notification about shareholding and encumbrance status, not a financial report or earnings release. It fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes or status in significant share ownership levels. The document length is short and focused on shareholding disclosure, confirming MRQ classification with high confidence.
2026-04-10 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter from Gujarat Themis Biosyn Limited addressed to stock exchanges (BSE and NSE) regarding a newspaper publication notice about a special window for re-lodgement of transfer requests and dematerialisation of physical shares. It references a SEBI circular and includes details about the publication in newspapers and availability on the company's website. The content is an announcement of a notice published in newspapers and does not contain financial statements, management discussion, or detailed financial data. The document length is about 15,000 characters but the content is primarily an announcement of a notice related to regulatory compliance and shareholder information. Therefore, it fits best as a Regulatory Filing (RNS) rather than a full report or financial document.
2026-04-08 English
Newspaper Publication of Notice to Shareholders for Special Window for re-lodgement of transfer requests and dematerialization of physical shares.
Regulatory Filings Classification · 95% confidence The document is a letter from Gujarat Themis Biosyn Limited addressed to stock exchanges (BSE and NSE) regarding a newspaper publication notice about a special window for re-lodgement of transfer requests and dematerialisation of physical shares. It references a SEBI circular and includes details about the publication in newspapers and availability on the company's website. The content is an announcement of a notice publication rather than a detailed report or financial statement. The document length is about 15,000 characters but the content is primarily an announcement of a notice related to share transfer and dematerialisation, not a financial report, earnings release, or regulatory filing with substantive financial data. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-04-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.